Inui Naoki相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52

TASUKI-52研究中，纳武利尤单抗联合化疗和贝伐单抗治疗非鳞状非小细胞肺癌患者的四年疗效

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.70330

Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko

细胞生物学

发表日期：2026

文献求助收藏

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD

血清干扰素-λ3作为抗MDA5阳性皮肌炎相关间质性肺病疾病控制的短期生物标志物

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-026-37104-x

Kitahara, Yoshihiro; Fujisawa, Tomoyuki; Fukada, Atsuki; Koda, Keigo; Akamatsu, Taisuke; Ikeda, Masaki; Fujii, Masato; Niwa, Mitsuru; Kaida, Yusuke; Matsuda, Hiroyuki; Yokomura, Koshi; Koshimizu, Naoki; Toyoshima, Mikio; Imokawa, Shiro; Hashimoto, Dai; Yamashita, Keita; Iwaizumi, Moriya; Maekawa, Masato; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Inui, Naoki; Suda, Takafumi

特发性肺纤维化

发表日期：2026

文献求助收藏

Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis.

冷诱导RNA结合蛋白促进成纤维细胞活化，抑制该蛋白是肺纤维化的潜在治疗靶点。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-026-39649-3

Mochizuka Yasutaka, Hozumi Hironao, Watanabe Hirofumi, Fukada Atsuki, Naoi Hyogo, Inoue Yusuke, Yasui Hideki, Suzuki Yuzo, Karayama Masato, Furuhashi Kazuki, Enomoto Noriyuki, Fujisawa Tomoyuki, Inui Naoki, Suda Takafumi

细胞生物学

成纤维细胞

发表日期：2026

文献求助收藏

Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)

TASUKI-52 简明语言摘要：一项研究，旨在探讨纳武利尤单抗联合铂类化疗和贝伐单抗作为治疗晚期或复发性非鳞状非小细胞肺癌 (NSCLC) 患者的联合疗法。

期刊:Future Oncology

影响因子:2.6

doi:10.1080/14796694.2026.2617855

Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko

细胞生物学

发表日期：2026

文献求助收藏

Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy

免疫相关不良事件与接受免疫检查点抑制剂治疗的癌症患者预后之间的关联

期刊:Internal Medicine

影响因子:1.1

doi:10.2169/internalmedicine.4654-24

Inoue, Yusuke; Inui, Naoki

免疫/内分泌

发表日期：2026

文献求助收藏

Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells.

小细胞肺癌细胞中 ASCL1 和 NEUROD1 的相互排斥表达是由于致命的共表达不耐受造成的

期刊:npj Precision Oncology

doi:10.1038/s41698-025-00860-6

Watanabe Hirofumi, Inoue Yusuke, Tsuchiya Kazuo, Asada Kazuhiro, Suzuki Makoto, Ogawa Hiroshi, Tanahashi Masayuki, Watanabe Takuya, Matsuura Shun, Yasuda Kazuyo, Ohnishi Ippei, Imokawa Shiro, Yasui Hideki, Karayama Masato, Suzuki Yuzo, Hozumi Hironao, Furuhashi Kazuki, Enomoto Noriyuki, Fujisawa Tomoyuki, Funai Kazuhito, Shinmura Kazuya, Sugimura Haruhiko, Inui Naoki, Suda Takafumi

细胞生物学

发表日期：2025

文献求助收藏

Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis

计算机断层扫描评估上叶正常肺容积对特发性胸膜肺实质纤维弹性病预后的价值

期刊:Erj Open Research

doi:10.1183/23120541.00687-2024

Suzuki, Yuzo; Kono, Masato; Hasegawa, Hirotsugu; Hashimoto, Dai; Yokomura, Koshi; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

发表日期：2025

文献求助收藏

Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia

分析特发性间质性肺炎患者支气管肺泡灌洗液淋巴细胞比例与自身免疫特征之间的关系

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-12180-7

Enomoto, Noriyuki; Watanuki, Masayuki; Nakai, Shogo; Yazawa, Shusuke; Mochizuka, Yasutaka; Fukada, Atsuki; Tanaka, Yuko; Naoi, Hyogo; Inoue, Yusuke; Yasui, Hideki; Karayama, Masato; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Toyoshima, Mikio; Kono, Masato; Imokawa, Shiro; Fujii, Masato; Akamatsu, Taisuke; Koshimizu, Naoki; Yokomura, Koshi; Matsuda, Hiroyuki; Kaida, Yusuke; Nakamura, Yutaro; Shirai, Masahiro; Mori, Kazutaka; Masuda, Masafumi; Fujisawa, Tomoyuki; Inui, Naoki; Sugiura, Hiroaki; Sumikawa, Hiromitsu; Kitani, Masashi; Tabata, Kazuhiro; Ogawa, Noriyoshi; Suda, Takafumi

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia

特发性间质性肺炎患者自身抗体在急性加重风险分层中的应用

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-19487-5

Yazawa, Shusuke; Enomoto, Noriyuki; Nakai, Shogo; Mochizuka, Yasutaka; Fukada, Atsuki; Tanaka, Yuko; Naoi, Hyogo; Inoue, Yusuke; Yasui, Hideki; Karayama, Masato; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Toyoshima, Mikio; Kono, Masato; Imokawa, Shiro; Fujii, Masato; Akamatsu, Taisuke; Koshimizu, Naoki; Yokomura, Koshi; Matsuda, Hiroyuki; Kaida, Yusuke; Nakamura, Yutaro; Shirai, Masahiro; Mori, Kazutaka; Masuda, Masafumi; Fujisawa, Tomoyuki; Inui, Naoki; Sugiura, Hiroaki; Sumikawa, Hiromitsu; Kitani, Masashi; Tabata, Kazuhiro; Ogawa, Noriyoshi; Suda, Takafumi

免疫/内分泌

发表日期：2025

文献求助收藏

Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study

家族性特发性肺纤维化抗纤维化治疗：一项比较队列研究

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-27730-2

Morikawa, Keisuke; Suzuki, Yuzo; Kato, Shinpei; Kono, Masato; Hashimoto, Dai; Yokomura, Koshi; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

特发性肺纤维化

发表日期：2025

文献求助收藏